EOM Pharmaceuticals (IMUC) News Today

$0.32

+0.14 (+77.78%)

(As of 12/4/2023 ET)

Compare

Today's Range: $0.17
▼
$0.32
50-Day Range: $0.17
▼
$0.33
52-Week Range: $0.15
▼
$0.93

Volume: 655 shs
Average Volume: 3,800 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Source

Source	Headline
	EOM Pharmaceuticals (OTCMKTS:IMUC) Trading Down 12.1% americanbankingnews.com - November 29 at 1:52 AM
	EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613 finance.yahoo.com - November 7 at 8:25 AM
	IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years markets.businessinsider.com - November 4 at 2:51 PM
	ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues msn.com - November 3 at 1:43 PM
	Oramed Pharmaceuticals Inc ORMP morningstar.com - November 1 at 5:45 PM
	Analyst Ratings for Olema Pharmaceuticals markets.businessinsider.com - October 11 at 1:29 PM
	EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil finance.yahoo.com - September 6 at 8:29 AM
	Q2 2023 PAVmed Inc Earnings Call uk.finance.yahoo.com - August 17 at 4:17 AM
	EOM Pharmaceuticals shelves plans to uplist shares, raise $15M msn.com - August 3 at 6:53 PM
	Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock benzinga.com - July 17 at 7:33 PM
	Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient marketwatch.com - July 3 at 6:05 PM
	Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment marketwatch.com - June 14 at 1:04 PM
	Trade commission fights Amgen's $28B purchase of Horizon Therapeutics msn.com - May 16 at 4:38 PM
	Pharma CEOs to testify in U.S. Senate hearing on insulin prices msn.com - May 10 at 5:12 PM
	8-K: Acumen Pharmaceuticals, Inc. marketwatch.com - May 10 at 12:09 PM
	Olema Pharmaceuticals GAAP EPS of -$0.70 misses by $0.04 msn.com - May 9 at 9:07 PM
	OliX Pharmaceuticals Inc (226950) investing.com - May 9 at 4:07 PM
	USFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug msn.com - March 30 at 8:43 AM
	U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents reuters.com - March 27 at 3:53 PM
	Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains marketwatch.com - March 13 at 6:22 PM
	EOM Pharmaceuticals Holdings, Inc. (IMUC) finance.yahoo.com - March 11 at 8:01 AM
	Ionis Pharmaceuticals, Inc. (IONS) Q4 2022 Earnings Call Transcript seekingalpha.com - February 24 at 9:16 AM
	AltruBio Hosting Research & Development Update on Immune Checkpoint Enhancer Platform for T Cell Mediated Immunological Diseases technews.tmcnet.com - December 8 at 8:41 AM
	Alaunos Therapeutics Shares Drop 24% After Public Offering Prices marketwatch.com - November 29 at 10:39 AM
	InVivo Therapeutics Adds to Surge After Hours, Recently at $10.85 marketwatch.com - October 6 at 10:46 PM
	Imunon Appoints James E. Dentzer to its Board of Directors benzinga.com - October 3 at 8:40 PM
	Seres Therapeutics Inc MCRB Stock Quote morningstar.com - September 21 at 4:36 PM
	ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics Conference benzinga.com - September 14 at 8:27 PM
	ImmunoCellular Therapeutics Ltd reuters.com - September 11 at 10:14 PM
	EOM Pharmaceutical Files For $25 Million IPO Uplisting To Nasdaq seekingalpha.com - June 28 at 2:46 AM
	EOM Pharmaceuticals files to uplist to Nasdaq seekingalpha.com - June 24 at 6:28 PM
	EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement finance.yahoo.com - December 2 at 9:50 AM
	Immunocellular Therapeutics Ltd (IMUC) nasdaq.com - July 17 at 9:34 PM
	ImmunoCellular Therapeutics Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market finance.yahoo.com - June 28 at 10:25 AM
	Dendritic Cell Therapy Market Insights By Size, Share, Future Growth And Forecast From 2020-2028 marketwatch.com - September 10 at 1:23 PM
	ImmunoCellular Therapeutics Ltd Registered Shs markets.businessinsider.com - August 8 at 1:32 PM
	ImmunoCellular Therapeutics Ltd. www.barrons.com - August 2 at 12:34 AM
	ImmunoCellular Therapeutics Announces Results of Special Meeting of Stockholders Held June 26, 2020 finance.yahoo.com - July 2 at 4:40 PM
	ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit finance.yahoo.com - October 16 at 5:45 PM
	ImmunoCellular Therapeutics Announces Completion of Asset Purchase Transaction with Private Biotechnology Company finance.yahoo.com - August 29 at 9:41 AM
	ImmunoCellular up 37% on asset sale seekingalpha.com - July 17 at 6:36 PM
	ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company finance.yahoo.com - July 16 at 7:11 PM
	Wolf Popper LLP Announces a Proposed Class Action Settlement for all Persons Who Purchased or Otherwise Acquired ImmunoCellular Therapeutics, Ltd. ("IMUC") Common Stock feeds.benzinga.com - March 22 at 3:55 PM
	Global Cancer Therapeutics Market to 2023 with Patents and Expiry Dates for Major Products by Leading Suppliers - GlobeNewswire globenewswire.com - February 5 at 6:24 PM

Get EOM Pharmaceuticals News Delivered to You Automatically

IMUC Media Mentions By Week

IMUC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMUC
News Sentiment
▼
0.50

0.70
▲
Average
Medical
News Sentiment

IMUC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMUC Articles
This Week
▼
2

0
▲
IMUC Articles
Average Week

Get EOM Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:IMUC) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

EOM Pharmaceuticals (IMUC) News Today

IMUC Media Mentions By Week

IMUC Media Sentiment

IMUC News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info